Results 131 to 140 of about 1,178 (159)
Some of the next articles are maybe not open access.
Polish journal of veterinary sciences, 2008
Canine visceral leishmaniosis (CVL) is an infectious disease of zoonotic potential, caused by protozoan parasite of the genus Leishmania. Common clinical manifestations of canine visceral leishmaniosis include decrease of appetite, progressive weight loss, exercise intolerance, peripheral lymph node and spleen enlargement, chronic renal and liver ...
openaire +1 more source
Canine visceral leishmaniosis (CVL) is an infectious disease of zoonotic potential, caused by protozoan parasite of the genus Leishmania. Common clinical manifestations of canine visceral leishmaniosis include decrease of appetite, progressive weight loss, exercise intolerance, peripheral lymph node and spleen enlargement, chronic renal and liver ...
openaire +1 more source
Unusual case of canine leishmaniosis in the UK
Veterinary Record, 2008SIR — We wish to report an unusual case of canine leishmaniosis that raises questions about the traditional sandfly ( Phlebotomus species) transmission of infection. A two-year-old male dog was presented to the University of Bristol Veterinary Hospital for investigation of an eight-week ...
S. E. Shaw, T. Hillman, J. Wray
openaire +1 more source
AgNOR Expression in Canine Visceral Leishmaniosis
2021One of the ways to assess cellular metabolism is through the AgNOR technique. Since NORs are related to protein synthesis, they are increased in number according to the increase in cell metabolism, which occurs when the cell enters the cell cycle. NORs are involved with active transcription during Leishmania spp infection and their activation can ...
openaire +2 more sources
Clinical efficacy and tolerance of miltefosine in the treatment of canine leishmaniosis
Parasitology Research, 2009The study was aimed to assess the efficacy and tolerance profiles of an oral administration miltefosine drug (Milteforan(R), Virbac) in dogs with natural leishmaniosis. In this multicentric open trial, 96 dogs were treated with the drug administered orally at a dose of 2 mg/kg body weight once a day for 28 days.
Virginie, Woerly +3 more
openaire +2 more sources
Canine leishmaniosis in a non‐travelled dog
Veterinary Record, 2023Yvonne, McGrotty +3 more
openaire +2 more sources
Canine Leishmaniosis: An Italian Emergency
Veterinary Research Communications, 2006GENCHI C, PIETROBELLI, MARIO
openaire +2 more sources
Canine Leishmaniosis: an expanding disease
2011Santos-Gomes, Gabriela +5 more
openaire +1 more source